Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and half year ending September 30, 2025. It is addressed to stock exchanges and references compliance with insider trading regulations. The document does not contain any financial data or results itself, nor does it present a report or detailed financial analysis. It is a regulatory announcement related to trading restrictions prior to financial results disclosure. Given the short length (1970 characters) and the nature of the content, this is not a financial report or earnings release but a regulatory filing informing about trading window closure. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-09-29 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter and half year ending September 30, 2025. It is addressed to stock exchanges and references compliance with insider trading regulations. The document does not contain any financial data or results itself, nor does it present a report. It is a regulatory announcement related to trading restrictions prior to financial results disclosure. The document length is short (1970 characters), and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-29 English
Updates
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the exercise price, and the resulting increase in the company's paid-up equity share capital. There is no financial performance data, no audit information, no meeting materials, no voting results, and no legal or merger information. The document is an announcement of a capital change specifically related to share allotment under an ESOP. According to the filing definitions, announcements regarding new share issues or capital changes fall under the category 'Share Issue/Capital Change' (SHA). The document length is short and it is a direct announcement, not a report or presentation. Therefore, the correct classification is SHA with high confidence.
2025-09-11 English
Allotment of ESOP
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the exercise price, and the resulting increase in the company's paid-up equity share capital. There are no financial statements, quarterly or annual results, or management discussion and analysis. The document is an announcement of a capital change due to share allotment under ESOP. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and contains specific details about share allotment, not just a notification or report publication, so it is not RPA or RNS. Hence, the classification is SHA with high confidence.
2025-09-11 English
Resignation of Mr. Vedprakash Ragate , Re-submitting with resignation letter as Annexure -B
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the resignation of a Whole-Time Executive Director of the company. It references compliance with SEBI Listing Regulations and includes annexures with resignation details and the resignation letter itself. There are no financial statements, earnings data, or report publications. The content clearly pertains to a change in senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2025-09-10 English
Resignation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the resignation of a Whole-Time Executive Director of the company. It references compliance with SEBI Listing Regulations and includes annexures with resignation details and the resignation letter itself. There is no financial data, earnings information, or report content. The document is an announcement of a management change, specifically the resignation of a director. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 4921 characters, which is consistent with a detailed announcement rather than a full report.
2025-09-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.